Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated May 16, 2016 (10 years ago)

VP-CH-PNV Prenatal/Postnatal capsules

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Defective delivery system: Softgel capsules are leaking.

Cause type: Packaging defect

Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.

What was recalled

VP-CH-PNV Prenatal/Postnatal capsules, prenatal supplement, 30-count bottle, Rx only, Manufactured for: Virtus Pharmaceuticals, LLC, Tampa, FL 33619, NDC 69543-224-30

Affected NDC 69543-0224-30

Compare with the code on your package — it is the most precise check available.

Recalling firm
Virtus Pharmaceuticals, Llc
NDC code
69543-224-30
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1048-2016 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Virtus Pharmaceuticals, Llc

All 2016 recalls
Class III · Low risk

Virt-Nate Prenatal/Postnatal

Tablets/Capsules Imprinted with Wrong ID; product debossed with an incorrect punch. Bottles could contain tablets debossed with V259 (debossing for PreTab) instead of the correct punch, V264 (debossing for Virt-Nate).

Terminated Labeling / mix-up Virtus Pharmaceuticals, Llc D-0775-2016

Other packaging defect recalls from 2016

All packaging defect recalls
Class III · Low risk

Azelastine Hydrochloride Nasal Solution

Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..

Terminated Packaging defect Roxane Laboratories, Inc. NDC 0054-0293-99 D-0448-2017
Class I · High risk

GlucaGen HypoKit

Defective delivery system: detached needles on the syringe in the kit.

Terminated Packaging defect Novo Nordisk Inc NDC 0169-7065-15 D-0217-2017
Class II · Moderate risk

Transderm Scop

Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.

Terminated Packaging defect Sandoz Inc D-0133-2017